Diana B Camarillo, MD
Dermatology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Office
- 1
- Since medical school
- 18 years
- University of California, San Francisco School of Medicine, 2008
Offices
1 location · Regents of the University of California - UCSF · 78 clinicians in this group
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Camarillo’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A109955 · Current
Licensed to practise in California · since 2009 · expires 2027-08-31 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$164,798
Medicare paid this office $164,798 for 450 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 287 | $29,514 | $77 |
| Destruction of skin growth, 1-14 growths | 129 | $16,847 | $101 |
| Return visit (30+ min) | 107 | $13,364 | $106 |
| Destruction of precancer skin growth, 1 growth | 198 | $12,094 | $46 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 27 | $9,910 | None |
See all 12 services
| Short return visit (20+ min) | 287 | $29,514 | $77 |
| Destruction of skin growth, 1-14 growths | 129 | $16,847 | $101 |
| Return visit (30+ min) | 107 | $13,364 | $106 |
| Destruction of precancer skin growth, 1 growth | 198 | $12,094 | $46 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 27 | $9,910 | None |
| Application of light with debridement to destroy precancer skin growth | 27 | $8,319 | $287 |
| Destruction of precancer skin growth, 2-14 growths | 166 | $6,045 | $6 |
| Biopsy of related skin growth, first growth | 64 | $5,658 | $79 |
| Destruction of precancer skin growth, 15 or more growths | 24 | $4,919 | $141 |
| New patient visit (30+ min) | 46 | $4,532 | $99 |
| New patient visit (45+ min) | 17 | $2,440 | $144 |
| Short return visit | 26 | $1,356 | $52 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of skin lesions | 615 | More than 89% of doctors who do this |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 74 | More than 73% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 671 | 561 | 959 | 916 | 887 | 978 |
| Destruction of precancer skin growth, 1 growth | 197 | 168 | 228 | 222 | 267 | 261 |
| Destruction of skin growth, 1-14 growths | 95 | 97 | 117 | 113 | 135 | 166 |
| Biopsy of related skin growth, first growth | 112 | 103 | 106 | 113 | 85 | 72 |
| Destruction of precancer skin growth, 15 or more growths | 15 | 19 | 35 | 44 | 50 | 35 |
| Biopsy of related skin growth, each additional growth | 33 | 16 | 25 | 19 | 15 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
450 Original Medicare patients in 2024. Average age 75 · Women 66% · Health risk score 0.73. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 45% · Coronary heart disease 17% · Cancer 17% · Atrial fibrillation 12% · Diabetes 11% · Chronic kidney disease 11% · Depression 11% · Heart failure 5% · COPD 5% · Stroke 4%.
The office billed $522,751, Medicare allowed $226,659 and paid $164,798; for 2,713 services of 37 kinds; $53,075 of it was for drugs given in the office and $111,723 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 450 | 2,713 | 75 | 0.73 | $522,751 | $164,798 |
| 2023 | 431 | 2,601 | 75 | 0.75 | $553,984 | $171,772 |
| 2022 | 424 | 2,560 | 74 | 0.71 | $503,180 | $154,393 |
| 2021 | 402 | 2,593 | 74 | 0.78 | $467,834 | $147,790 |
| 2020 | 337 | 1,843 | 74 | 0.77 | $368,051 | $109,014 |
| 2019 | 367 | 1,758 | 74 | 0.77 | $205,082 | $80,849 |
| 2018 | 309 | 1,512 | 74 | 0.80 | $163,702 | $67,608 |
| 2017 | 188 | 791 | 73 | 0.80 | $92,654 | $38,389 |
| 2016 | 218 | 1,087 | 74 | 0.92 | $143,997 | $59,185 |
| 2015 | 196 | 1,001 | 73 | 0.74 | $108,305 | $45,129 |
| 2014 | 182 | 882 | 75 | 0.81 | $94,952 | $42,851 |
| 2013 | 56 | 169 | 73 | 0.68 | $19,802 | $9,906 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Short return visit (20+ min) | 268 | $28,494 | $78 |
| Destruction of skin growth, 1-14 growths | 97 | $14,707 | $109 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 32 | $13,177 | None |
| Destruction of precancer skin growth, 1 growth | 197 | $12,625 | $47 |
| Return visit (30+ min) | 93 | $11,841 | $102 |
| Application of light with debridement to destroy precancer skin growth | 32 | $10,830 | $278 |
| Destruction of precancer skin growth, 15 or more growths | 36 | $7,751 | $155 |
| Biopsy of related skin growth, first growth | 70 | $7,048 | $83 |
| Destruction of precancer skin growth, 2-14 growths | 155 | $5,341 | $6 |
| New patient visit (30+ min) | 64 | $5,215 | $81 |
| New patient visit (45+ min) | 13 | $1,701 | $131 |
| Injection into skin growth, 1-7 growths | 11 | $973 | $41 |
| Short return visit | 16 | $817 | $51 |
| Biopsy of related skin growth, each additional growth | 11 | $717 | $48 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $20 | None |
2022: 13 services
| Short return visit (20+ min) | 276 | $29,032 | $76 |
| Destruction of skin growth, 1-14 growths | 90 | $11,122 | $98 |
| Return visit (30+ min) | 92 | $10,414 | $101 |
| Destruction of precancer skin growth, 1 growth | 171 | $10,225 | $46 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 19 | $8,970 | None |
| Biopsy of related skin growth, first growth | 93 | $8,259 | $73 |
| Application of light with debridement to destroy precancer skin growth | 19 | $6,914 | $301 |
| Destruction of precancer skin growth, 15 or more growths | 31 | $6,079 | $138 |
| Destruction of precancer skin growth, 2-14 growths | 144 | $5,241 | $6 |
| New patient visit (30+ min) | 53 | $4,215 | $80 |
| New patient visit (45+ min) | 12 | $1,797 | $150 |
| Short return visit | 38 | $1,723 | $44 |
| Biopsy of related skin growth, each additional growth | 15 | $927 | $49 |
2021: 11 services
| Short return visit (20+ min) | 272 | $30,023 | $78 |
| Destruction of skin growth, 1-14 growths | 95 | $11,702 | $100 |
| Return visit (30+ min) | 83 | $11,287 | $113 |
| Destruction of precancer skin growth, 1 growth | 170 | $10,184 | $45 |
| Biopsy of related skin growth, first growth | 88 | $8,587 | $81 |
| Destruction of precancer skin growth, 2-14 growths | 137 | $5,633 | $6 |
| Destruction of precancer skin growth, 15 or more growths | 25 | $5,089 | $145 |
| New patient visit (30+ min) | 56 | $4,858 | $87 |
| New patient visit (45+ min) | 14 | $2,065 | $148 |
| Short return visit | 23 | $1,239 | $52 |
| Biopsy of related skin growth, each additional growth | 16 | $1,201 | $48 |
2020: 11 services
| Short return visit (20+ min) | 217 | $21,148 | $67 |
| Destruction of skin growth, 1-14 growths | 82 | $9,715 | $100 |
| Biopsy of related skin growth, first growth | 90 | $8,177 | $79 |
| Destruction of precancer skin growth, 1 growth | 138 | $6,971 | $41 |
| Return visit (30+ min) | 52 | $5,245 | $90 |
| New patient visit (30+ min) | 56 | $5,188 | $93 |
| Destruction of precancer skin growth, 2-14 growths | 110 | $3,064 | $5 |
| Destruction of precancer skin growth, 15 or more growths | 14 | $2,578 | $136 |
| New patient visit (15+ min) | 20 | $1,249 | $62 |
| Short return visit | 23 | $987 | $43 |
| Biopsy of related skin growth, each additional growth | 14 | $707 | $44 |
2019: 12 services
| Short return visit (20+ min) | 255 | $22,056 | $62 |
| Destruction of skin growth, 1-14 growths | 80 | $9,856 | $104 |
| Destruction of precancer skin growth, 1 growth | 143 | $9,694 | $49 |
| Biopsy of related skin growth, first growth | 95 | $9,613 | $86 |
| Return visit (30+ min) | 64 | $6,255 | $88 |
| New patient visit (30+ min) | 49 | $4,450 | $91 |
| Destruction of precancer skin growth, 2-14 growths | 116 | $3,550 | $5 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 13 | $2,166 | $167 |
| Destruction of precancer skin growth, 15 or more growths | 12 | $2,083 | $139 |
| Biopsy of related skin growth, each additional growth | 24 | $1,571 | $48 |
| Short return visit | 27 | $1,121 | $39 |
| New patient visit (15+ min) | 17 | $980 | $58 |
2018: 11 services
| Short return visit (20+ min) | 211 | $16,676 | $58 |
| Biopsy of single growth of skin and/or tissue | 91 | $10,347 | $96 |
| Destruction of precancer skin growth, 1 growth | 132 | $8,450 | $47 |
| Return visit (30+ min) | 62 | $7,051 | $89 |
| New patient visit (30+ min) | 68 | $5,629 | $83 |
| Destruction of skin growth, 1-14 growths | 40 | $5,169 | $101 |
| Destruction of precancer skin growth, 2-14 growths | 98 | $2,850 | $5 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 13 | $2,205 | $170 |
| Short return visit | 29 | $1,130 | $36 |
| New patient visit (15+ min) | 14 | $857 | $61 |
| Biopsy of each additional growth of skin and/or tissue | 13 | $455 | $30 |
2017: 8 services
| Short return visit (20+ min) | 112 | $8,045 | $61 |
| Biopsy of single growth of skin and/or tissue | 65 | $6,582 | $90 |
| Destruction of precancer skin growth, 1 growth | 75 | $4,267 | $48 |
| Return visit (30+ min) | 41 | $4,254 | $91 |
| New patient visit (30+ min) | 43 | $3,543 | $82 |
| Destruction of skin growth, 1-14 growths | 23 | $2,523 | $97 |
| Destruction of precancer skin growth, 2-14 growths | 57 | $1,607 | $5 |
| Short return visit | 18 | $852 | $36 |
2016: 10 services
| Short return visit (20+ min) | 105 | $9,344 | $58 |
| Biopsy of single growth of skin and/or tissue | 68 | $8,648 | $93 |
| New patient visit (30+ min) | 87 | $6,498 | $75 |
| Return visit (30+ min) | 48 | $6,149 | $93 |
| Destruction of precancer skin growth, 1 growth | 80 | $5,586 | $48 |
| Destruction of skin growth, 1-14 growths | 33 | $3,813 | $100 |
| Destruction of precancer skin growth, 15 or more growths | 14 | $2,258 | $133 |
| Destruction of precancer skin growth, 2-14 growths | 61 | $1,932 | $6 |
| Short return visit | 42 | $1,848 | $36 |
| Biopsy of each additional growth of skin and/or tissue | 16 | $610 | $30 |
2015: 7 services
| Short return visit (20+ min) | 115 | $11,552 | $62 |
| New patient visit (30+ min) | 84 | $7,284 | $87 |
| Biopsy of single growth of skin and/or tissue | 64 | $6,776 | $94 |
| Destruction of precancer skin growth, 1 growth | 86 | $5,520 | $47 |
| Destruction of skin growth, 1-14 growths | 41 | $4,261 | $89 |
| Destruction of precancer skin growth, 2-14 growths | 68 | $2,269 | $6 |
| Short return visit | 26 | $1,181 | $42 |
2014: 9 services
| Short return visit (20+ min) | 106 | $9,455 | $62 |
| Destruction of precancer skin growth, 1 growth | 72 | $5,988 | $59 |
| New patient visit (30+ min) | 72 | $5,919 | $82 |
| Biopsy of single growth of skin and/or tissue | 45 | $4,765 | $90 |
| Destruction of skin growth, 1-14 growths | 39 | $4,617 | $105 |
| Destruction of precancer skin growth, 2-14 growths | 57 | $3,783 | $10 |
| Return visit (30+ min) | 12 | $1,416 | $94 |
| New patient visit (15+ min) | 13 | $747 | $57 |
| Short return visit | 13 | $631 | $42 |
2013: 5 services
| Short return visit (20+ min) | 34 | $2,333 | $65 |
| New patient visit (30+ min) | 22 | $2,229 | $101 |
| Biopsy of single growth of skin and/or tissue | 15 | $1,474 | $98 |
| Destruction of precancer skin growth, 1 growth | 16 | $1,272 | $75 |
| Destruction of precancer skin growth, 2-14 growths | 12 | $364 | $6 |
Drugs they prescribed that Part D paid
$26,625
Pharmacies billed $26,625 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 321) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
306 generic and 15 brand-name prescriptions · $26,625 in drug cost · 20 antibiotic prescriptions to 15 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Betamethasone Dipropionate | 16 | $880 | $55 |
| Fluorouracil | 13 | $838 | $64 |
| Fluocinonide | 27 | $800 | $30 |
| Ketoconazole | 61 | $779 | $13 |
| Valacyclovir | 15 | $763 | $51 |
See all 8 drugs
| Betamethasone Dipropionate | 16 | $880 | $55 |
| Fluorouracil | 13 | $838 | $64 |
| Fluocinonide | 27 | $800 | $30 |
| Ketoconazole | 61 | $779 | $13 |
| Valacyclovir | 15 | $763 | $51 |
| Doxycycline Hyclate | 21 | $690 | $33 |
| Clobetasol Propionate | 23 | $670 | $29 |
| Triamcinolone Acetonide | 42 | $339 | $8 |
Year by year
| 2024 | 321 | 165 | 0% (0) | 5% | $26,625 |
| 2023 | 347 | 152 | 0% (0) | None | $14,199 |
| 2022 | 315 | 157 | 0% (0) | None | $15,009 |
| 2021 | 353 | 141 | 0% (0) | 7% | $17,483 |
| 2020 | 267 | 122 | 0% (0) | 6% | $21,845 |
| 2019 | 276 | 99 | 0% (0) | 13% | $48,215 |
| 2018 | 257 | 112 | 0% (0) | 14% | $15,637 |
| 2017 | 145 | 60 | 0% (0) | 10% | $15,274 |
| 2016 | 197 | 76 | 0% (0) | 14% | $22,904 |
| 2015 | 153 | 76 | 0% (0) | 22% | $17,737 |
| 2014 | 205 | 104 | 0% (0) | 15% | $9,415 |
| 2013 | 72 | 33 | 0% (0) | 24% | $18,755 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Metronidazole | 19 | $1,714 | $90 |
| Fluorouracil | 14 | $1,646 | $118 |
| Betamethasone Dipropionate | 19 | $1,417 | $75 |
| Doxycycline Hyclate | 27 | $1,403 | $52 |
| Fluocinonide | 32 | $1,119 | $35 |
| Clobetasol Propionate | 32 | $1,012 | $32 |
| Ketoconazole | 47 | $644 | $14 |
| Triamcinolone Acetonide | 61 | $449 | $7 |
| Dexamethasone | 11 | $246 | $22 |
| Valacyclovir | 14 | $235 | $17 |
2022: 11 drugs
| Betamethasone Dipropionate | 27 | $2,096 | $78 |
| Fluocinonide | 24 | $1,165 | $49 |
| Fluorouracil | 13 | $1,163 | $89 |
| Doxycycline Hyclate | 25 | $1,090 | $44 |
| Metronidazole | 12 | $880 | $73 |
| Clobetasol Propionate | 16 | $838 | $52 |
| Ketoconazole | 30 | $446 | $15 |
| Valacyclovir | 16 | $411 | $26 |
| Triamcinolone Acetonide | 72 | $398 | $6 |
| Mupirocin | 12 | $131 | $11 |
| Hydrocortisone | 12 | $70 | $6 |
2021: 9 drugs
| Fluocinonide | 33 | $2,541 | $77 |
| Betamethasone Dipropionate | 23 | $1,701 | $74 |
| Doxycycline Hyclate | 37 | $1,436 | $39 |
| Ketoconazole | 55 | $1,023 | $19 |
| Clobetasol Propionate | 17 | $762 | $45 |
| Metronidazole | 11 | $755 | $69 |
| Valacyclovir | 16 | $735 | $46 |
| Triamcinolone Acetonide | 57 | $479 | $8 |
| Hydrocortisone | 19 | $121 | $6 |
2020: 7 drugs
| Doxycycline Hyclate | 29 | $1,285 | $44 |
| Metronidazole | 12 | $956 | $80 |
| Clobetasol Propionate | 14 | $909 | $65 |
| Fluocinonide | 20 | $899 | $45 |
| Ketoconazole | 34 | $648 | $19 |
| Triamcinolone Acetonide | 41 | $318 | $8 |
| Hydrocortisone | 15 | $74 | $5 |
2019: 8 drugs
| Fluocinonide | 28 | $1,674 | $60 |
| Doxycycline Hyclate | 33 | $1,552 | $47 |
| Clobetasol Propionate | 16 | $1,223 | $76 |
| Betamethasone Dipropionate | 12 | $1,135 | $95 |
| Ketoconazole | 31 | $483 | $16 |
| Triamcinolone Acetonide | 22 | $335 | $15 |
| Nystop | 12 | $245 | $20 |
| Hydrocortisone | 11 | $46 | $4 |
2018: 6 drugs
| Betamethasone Dipropionate | 22 | $1,690 | $77 |
| Fluocinonide | 23 | $1,193 | $52 |
| Doxycycline Hyclate | 27 | $1,159 | $43 |
| Metronidazole | 13 | $932 | $72 |
| Triamcinolone Acetonide | 28 | $215 | $8 |
| Ketoconazole | 12 | $160 | $13 |
2017: 5 drugs
| Hydroxychloroquine Sulfate | 11 | $1,202 | $109 |
| Metronidazole | 11 | $1,077 | $98 |
| Clobetasol Propionate | 11 | $982 | $89 |
| Doxycycline Hyclate | 15 | $721 | $48 |
| Triamcinolone Acetonide | 19 | $199 | $10 |
2016: 5 drugs
| Clobetasol Propionate | 20 | $2,273 | $114 |
| Hydroxychloroquine Sulfate | 14 | $1,332 | $95 |
| Fluocinonide | 22 | $1,049 | $48 |
| Doxycycline Hyclate | 12 | $449 | $37 |
| Triamcinolone Acetonide | 16 | $300 | $19 |
2015: 4 drugs
| Clobetasol Propionate | 28 | $4,494 | $160 |
| Fluocinonide | 16 | $972 | $61 |
| Desonide | 19 | $957 | $50 |
| Doxycycline Monohydrate | 12 | $382 | $32 |
2014: 4 drugs
| Clobetasol Propionate | 45 | $1,916 | $43 |
| Desonide | 16 | $1,228 | $77 |
| Fluocinonide | 13 | $551 | $42 |
| Mometasone Furoate | 27 | $512 | $19 |
2013: 1 drug
| Clobetasol Propionate | 14 | $543 | $39 |
Money from drug and device companies
$1,612 in 2025
| 2025 | 15 | 57 | None | $1,612 |
| 2024 | 13 | 36 | None | $910 |
| 2023 | 16 | 82 | None | $1,375 |
| 2022 | 15 | 36 | None | $868 |
| 2021 | 4 | 23 | None | $466 |
| 2020 | 2 | 5 | None | $172 |
| 2019 | 7 | 12 | None | $548 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Arcutis Biotherapeutics | Zoryve | $275 | 7 payments
|
| Abbvie | Botox | $271 | 12 payments
|
| Organon | Vtama | $246 | 3 payments
|
| Incyte | Opzelura | $194 | 8 payments
|
| Sun Pharmaceutical Industries | Winlevi | $176 | 8 payments
|
| Galderma Laboratories L.P. | Nemluvio | $150 | 6 payments
|
See all 57 published payments
| Galderma Laboratories L.P. | Meals · 2025-12-16 | None | $25 |
| Abbvie | Meals · 2025-12-12 | Skyrizi | $15 |
| Genzyme | Meals · 2025-12-11 | Dupixent | $16 |
| Abbvie | Meals · 2025-12-10 | Botox | $12 |
| Incyte | Meals · 2025-12-09 | Opzelura | $27 |
| Arcutis Biotherapeutics | Meals · 2025-11-21 | Zoryve | $18 |
| Incyte | Meals · 2025-11-19 | Opzelura | $23 |
| Galderma Laboratories L.P. | Meals · 2025-11-15 | None | $21 |
| Novartis Pharmaceuticals | Meals · 2025-11-13 | Rhapsido | $33 |
| Genzyme | Meals · 2025-11-13 | Dupixent | $16 |
| Sun Pharmaceutical Industries | Meals · 2025-11-12 | Winlevi | $11 |
| Organon | Meals · 2025-11-06 | Vtama | $15 |
| Arcutis Biotherapeutics | Meals · 2025-11-04 | Zoryve | $15 |
| Sun Pharmaceutical Industries | Meals · 2025-10-31 | Winlevi | $13 |
| Arcutis Biotherapeutics | Meals · 2025-10-23 | Zoryve | $11 |
| Abbvie | Meals · 2025-10-15 | Botox | $32 |
| Incyte | Meals · 2025-10-14 | Opzelura | $32 |
| Abbvie | Meals · 2025-10-08 | Skyrizi | $29 |
| Arcutis Biotherapeutics | Meals · 2025-09-29 | Zoryve | $15 |
| Regeneron Healthcare Solutions | Meals · 2025-09-27 | Dupixent | $17 |
| Sun Pharmaceutical Industries | Meals · 2025-09-23 | Leqselvi | $31 |
| Sun Pharmaceutical Industries | Meals · 2025-09-23 | Leqselvi | $2 |
| Arcutis Biotherapeutics | Meals · 2025-09-19 | Zoryve | $162 |
| Biofrontera | Meals · 2025-09-17 | None | $22 |
| Abbvie | Meals · 2025-09-15 | Skyrizi | $16 |
| Galderma Laboratories L.P. | Meals · 2025-09-05 | Nemluvio | $40 |
| Abbvie | Meals · 2025-08-29 | Botox | $33 |
| Incyte | Meals · 2025-08-27 | Opzelura | $26 |
| Galderma Laboratories L.P. | Meals · 2025-08-22 | None | $33 |
| Incyte | Meals · 2025-08-13 | Opzelura | $14 |
| Sun Pharmaceutical Industries | Meals · 2025-08-12 | Winlevi | $31 |
| Arcutis Biotherapeutics | Meals · 2025-08-05 | Zoryve | $16 |
| Arcutis Biotherapeutics | Meals · 2025-08-05 | Zoryve | $38 |
| Amgen | Meals · 2025-08-04 | Otezla | $17 |
| LEO Pharma | Meals · 2025-08-01 | Adbry | $14 |
| Incyte | Meals · 2025-07-22 | Opzelura | $15 |
| Sun Pharmaceutical Industries | Meals · 2025-06-18 | Winlevi | $32 |
| Abbvie | Meals · 2025-06-17 | Rinvoq | $15 |
| Abbvie | Meals · 2025-06-16 | Rinvoq | $28 |
| Abbvie | Meals · 2025-06-12 | Skyrizi | $8 |
| Sun Pharmaceutical Industries | Meals · 2025-06-02 | Winlevi | $26 |
| Abbvie | Meals · 2025-05-16 | Botox | $29 |
| Incyte | Meals · 2025-05-09 | Opzelura | $28 |
| Sun Pharmaceutical Industries | Meals · 2025-04-24 | Winlevi | $30 |
| Incyte | Meals · 2025-04-16 | Opzelura | $29 |
| Abbvie | Meals · 2025-04-15 | Skyrizi | $26 |
| Amgen | Meals · 2025-04-11 | Otezla | $28 |
| Organon | Meals · 2025-04-10 | Vtama | $200 |
| Amgen | Meals · 2025-03-03 | Otezla | $27 |
| Pfizer | Meals · 2025-02-26 | Litfulo | $30 |
| Galderma Laboratories L.P. | Meals · 2025-02-07 | None | $4 |
| Galderma Laboratories L.P. | Meals · 2025-01-30 | Nemluvio | $27 |
| Lilly USA | Meals · 2025-01-27 | Taltz | $29 |
| Janssen Biotech | Meals · 2025-01-24 | Tremfya | $19 |
| Pfizer | Meals · 2025-01-21 | Litfulo | $31 |
| Abbvie | Meals · 2025-01-17 | Rinvoq | $27 |
| Organon | Meals · 2025-01-08 | Vtama | $32 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $910
| Abbvie | Skyrizi | $197 | 10 payments
|
| Genzyme | Dupixent | $163 | 6 payments
|
| Amgen | Otezla | $94 | 3 payments
|
| Arcutis Biotherapeutics | Zoryve | $88 | 3 payments
|
| Pfizer | Litfulo | $55 | 2 payments
|
| Incyte | Opzelura | $54 | 2 payments
|
| Galderma Laboratories L.P. | None | $53 | 2 payments
|
| Janssen Biotech | Tremfya | $51 | 2 payments
|
| Lilly USA | Taltz | $34 | 1 payment
|
| Ucb | Bimzelx | $33 | 1 payment
|
| Dermavant Sciences | Vtama | $32 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $31 | 1 payment
|
| Biofrontera | Ameluz | $25 | 2 payments
|
2023: $1,375
| AbbVie | Skyrizi | $241 | 22 payments
|
| Incyte | Opzelura | $189 | 21 payments
|
| Pfizer | Litfulo | $188 | 4 payments
|
| Sun Pharmaceutical Industries | Winlevi | $142 | 12 payments
|
| Dermavant Sciences | Vtama | $97 | 4 payments
|
| Amgen | Otezla | $91 | 3 payments
|
| Lilly USA | Taltz | $88 | 3 payments
|
| Genzyme | Dupixent | $86 | 3 payments
|
| Merz North America | Xeomin | $75 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $31 | 1 payment
|
| Genentech USA | Xolair | $31 | 1 payment
|
| STRATA Skin Sciences | Xtrac | $29 | 1 payment
|
| Almirall | Klisyri | $24 | 1 payment
|
| Ucb | Bimzelx | $22 | 1 payment
|
| LEO Pharma | Adbry | $22 | 1 payment
|
| Janssen Biotech | Tremfya | $21 | 1 payment
|
2022: $868
| Allergan | Botox | $158 | 4 payments
|
| LEO Pharma | Adbry | $140 | 8 payments
|
| Merz North America | Xeomin | $85 | 4 payments
|
| Lilly USA | Taltz | $80 | 3 payments
|
| Sun Pharmaceutical Industries | Winlevi | $74 | 3 payments
|
| Janssen Biotech | Remicade | $54 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $50 | 2 payments
|
| Amgen | Otezla | $44 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $31 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $30 | 1 payment
|
| Pfizer | Cibinqo | $29 | 1 payment
|
| Dermavant Sciences | Vtama | $27 | 1 payment
|
| Incyte | Opzelura | $23 | 1 payment
|
| Abbvie | Humira | $22 | 1 payment
|
| Genzyme | Dupixent | $21 | 1 payment
|
2021: $466
| Merz North America | None | $307 | 6 payments
|
| LEO Pharma | Enstilar | $116 | 15 payments
|
| AbbVie | Skyrizi | $26 | 1 payment
|
| Allergan | None | $18 | 1 payment
|
2020: $172
| Merz North America | Xeomin | $129 | 2 payments
|
| Allergan | Botox Cosmetic | $42 | 3 payments
|
2019: $548
| AbbVie | Skyrizi | $150 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $128 | 2 payments
|
| Sun Pharmaceutical Industries | Ilumya | $121 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $49 | 2 payments
|
| LEO Pharma | Enstilar | $45 | 3 payments
|
| Merz North America | None | $31 | 2 payments
|
| Galderma Laboratories L.P. | Epiduo Forte | $24 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1750610861
- Licence
- CA A109955California A109955: Current · expires 2027-08-31
- Trained
- University of California, San Francisco School of Medicine, 2008 · 18 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 2211 Post Street, Suite 404, San Francisco, CA, 94115
- NPI first listed
- 2009-12-18
- NPI last updated
- 2016-02-26
This is when the NPI record was last certified, not a medical board exam.